Literature DB >> 19438853

Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis.

K Wichmann1, W Uter, J Weiss, K Breuer, A Heratizadeh, U Mai, T Werfel.   

Abstract

BACKGROUND: Staphylococcus aureus (S. aureus) is a well-known trigger factor of atopic dermatitis (AD). Besides staphylococcal superantigens, alpha-toxin may influence cutaneous inflammation via induction of T-cell proliferation and cytokine secretion.
OBJECTIVES: To investigate the association between sensitization to inhalant allergens and skin colonization with alpha-toxin-producing S. aureus in AD. PATIENTS AND METHODS: We investigated 127 patients with AD, aged 14-65 years, who were on standard anti-inflammatory and antiseptic treatment before investigation. We evaluated skin colonization, medical history, severity of AD and sensitization to inhalant allergens.
RESULTS: Forty-eight of 127 patients were colonized with S. aureus, suffered from more severe AD, had asthma more often and showed higher sensitization levels to inhalant allergens. Thirty of 48 patients with S. aureus skin-colonizing strains produced alpha-toxin and had higher total IgE and specific IgE to birch pollen and timothy grass pollen.
CONCLUSIONS: Under topical treatment with antiseptic and anti-inflammatory agents the colonization of lesional skin with S. aureus was clearly lower than commonly found in untreated patients with AD. Colonization with S. aureus was associated with a higher severity of AD, higher degree of sensitization, and a higher frequency of asthma. The proportion of patients whose skin was colonized with alpha-toxin-producing S. aureus was higher than expected from a former study. Cutaneous colonization with alpha-toxin-producing S. aureus was associated with a higher sensitization level to birch pollen allergen in AD. This may point to a higher susceptibility of patients with higher T-helper 2 polarization towards alpha-toxin-producing S. aureus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438853     DOI: 10.1111/j.1365-2133.2009.09229.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

1.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus.

Authors:  A de Breij; T G Karnaoukh; J Schrumpf; P S Hiemstra; P H Nibbering; J T van Dissel; P C de Visser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-15       Impact factor: 3.267

Review 3.  [Specific immunotherapy and atopic dermatitis. What is new?].

Authors:  N Novak; T Werfel
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

4.  [Adaptive immune response and associated trigger factors in atopic dermatitis].

Authors:  A Heratizadeh; T Werfel; L M Rösner
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

5.  Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic Dermatitis.

Authors:  Orla M Fleury; Maeve A McAleer; Cécile Feuillie; Cécile Formosa-Dague; Emily Sansevere; Désirée E Bennett; Aisling M Towell; W H Irwin McLean; Sanja Kezic; D Ashley Robinson; Padraic G Fallon; Timothy J Foster; Yves F Dufrêne; Alan D Irvine; Joan A Geoghegan
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

6.  Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans.

Authors:  Margarete Niebuhr; Merle Gathmann; Helena Scharonow; Diana Mamerow; Susanne Mommert; Hari Balaji; Thomas Werfel
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

7.  Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions.

Authors:  A Kozman; Y Yao; P Bina; C Saha; W Yao; M H Kaplan; J B Travers
Journal:  Br J Dermatol       Date:  2010-12       Impact factor: 9.302

Review 8.  The infectious aspects of atopic dermatitis.

Authors:  Peck Y Ong; Donald Y M Leung
Journal:  Immunol Allergy Clin North Am       Date:  2010-07-01       Impact factor: 3.479

9.  Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort.

Authors:  Tammy Gonzalez; Mariana L Stevens; Asel Baatyrbek Kyzy; Rosario Alarcon; Hua He; John W Kroner; Daniel Spagna; Brittany Grashel; Elaine Sidler; Lisa J Martin; Jocelyn M Biagini Myers; Gurjit K Khurana Hershey; Andrew B Herr
Journal:  Allergy       Date:  2020-08-09       Impact factor: 13.146

10.  Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte death.

Authors:  Anne M Brauweiler; Lianghua Bin; Byung Eui Kim; Michiko K Oyoshi; Raif S Geha; Elena Goleva; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2012-12-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.